Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Universidade de Vigo | Spain

Dr. Lorena García Hevia is a distinguished researcher recognized for her pioneering work at the intersection of nanomedicine, microbiology, and biotechnology. As a member of the Hybrid Nanomaterials Research Group at the Galicia Sur Health Research Institute (IIS Galicia Sur), she has dedicated her career to advancing innovative nanotechnological solutions that address critical biomedical challenges. Her research focuses primarily on the design and application of nanoscale systems to improve therapeutic delivery, particularly within the context of infectious disease management and antimicrobial resistance.Affiliated with the CINBIO (Biomedical Research Center) and the Universidade de Vigo in Spain, Dr. García Hevia brings an interdisciplinary approach that bridges biochemical, genetic, and immunological insights with advanced materials science. Her scientific vision emphasizes the development of intelligent nanocarriers that enhance drug stability, optimize bioavailability, and enable targeted therapy. Through this approach, she contributes to transforming conventional treatments into highly efficient, patient-specific solutions.In her recent publication Nanomedicine for Phage Therapy: Encapsulation Strategies for Enhanced Antimicrobial Efficacy, Dr. García Hevia and her colleagues explore the integration of nanotechnology with bacteriophage therapy to overcome limitations in traditional antimicrobial strategies. Her work demonstrates how encapsulation methods—such as polymeric nanoparticles, liposomes, hydrogels, and nanofibers—can significantly improve the stability, delivery, and therapeutic impact of bacteriophages. These innovative formulations facilitate localized and sustained release, providing powerful alternatives against multidrug-resistant infections.Dr. García Hevia’s research is marked by creativity, precision, and translational relevance. Her investigations into responsive nanocarriers and inorganic nanoparticles have opened new avenues for targeted phage delivery, aligning with global efforts to combat antibiotic resistance through sustainable and effective biotechnological interventions. Beyond her scientific achievements, she is deeply engaged in academic mentorship and collaborative research initiatives that strengthen the connection between laboratory innovation and clinical application.Her contributions continue to shape the evolving field of nanomedicine, positioning her as a leading figure in the development of next-generation antimicrobial therapies. Through her commitment to excellence and scientific innovation, Dr. Lorena García Hevia exemplifies the transformative potential of nanotechnology in redefining the future of infection control and precision therapeutics.

Profile: Google Scholar

Featured Publications

García‐Hevia, L., Bañobre‐López, M., & Gallo, J. (2019). Recent progress on manganese‐based nanostructures as responsive MRI contrast agents. Chemistry–A European Journal, 25(2), 431–441.

García-Hevia, L., Valiente, R., Martín-Rodríguez, R., Renero-Lecuna, C., et al. (2016). Nano-ZnO leads to tubulin macrotube assembly and actin bundling, triggering cytoskeletal catastrophe and cell necrosis. Nanoscale, 8(21), 10963–10973.

Rodrigues, R. O., Baldi, G., Doumett, S., García-Hevia, L., Gallo, J., et al. (2018). Multifunctional graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug delivery. Materials Science and Engineering: C, 93, 206–217.

García‐Hevia, L., Villegas, J. C., Fernández, F., Casafont, Í., González, J., et al. (2016). Multiwalled carbon nanotubes inhibit tumor progression in a mouse model. Advanced Healthcare Materials, 5(9), 1080–1087.

García-Hevia, L., Casafont, I., Oliveira, J., Terán, N., Fanarraga, M. L., & Gallo, J. (2022). Magnetic lipid nanovehicles synergize the controlled thermal release of chemotherapeutics with magnetic ablation while enabling non-invasive monitoring by MRI for melanoma. Bioactive Materials, 8, 153–164.

Teodora-Eliana Petcov | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Teodora-Eliana Petcov | Drug Delivery Systems | Best Researcher Award

Teodora-Eliana Petcov at National University of Science and Technology POLITEHNICA Bucharest | Romania

Teodora Eliana Petcov is a driven biomedical researcher with a strong foundation in biomaterials, molecular biology, and nanotechnology. Passionate about innovation in drug delivery and regenerative medicine, she has already co-authored scientific publications in reputed journals. Her international internships, multidisciplinary skills, and involvement in EU-funded research projects underscore her commitment to advancing medical technologies. Teodora balances research excellence with volunteer leadership, contributing to both academic and community-driven initiatives. With a sharp analytical mind, hands-on lab experience, and cross-cultural exposure, she exemplifies the next generation of biomedical scientists focused on improving patient care through science and innovation.

Publication Profile 

Scopus

Education

Teodora holds a Bachelor’s degree in Medical Engineering from the Polytechnic University of Bucharest  with a focus on biomaterials and medical devices. She is currently pursuing her Master’s in Biocompatible Substances, Materials, and Systems at the National University of Science and Technology POLITEHNICA Bucharest. Her thesis explored the internalization of nano-sized devices in biological structures. She was a visiting student at “Horia Hulubei” Nuclear Institute and Floreasca Emergency Hospital. Her academic path is complemented by certifications in English  and psycho-pedagogical training, showcasing both technical expertise and educational versatility.

Experience 

Teodora has completed multiple research internships, including roles in molecular biology and materials science labs. She gained practical expertise in 3D bioprinting, SEM techniques, SolidWorks, and conducted advanced testing like DSC and DMA. She has contributed to projects at the National Institute of Physics and Nuclear Engineering, University of Campania in Italy, and worked on PNRR-funded research on bone regeneration and multiple myeloma. Additionally, she has volunteered extensively in cultural and scientific event organization, holding assistant coordinator roles in Zenezia and MED, where she honed human resources, leadership, and scientific communication skills.

Awards  

Teodora has been recognized for her academic excellence and community involvement from high school through higher education. She received top honors for her Bachelor’s thesis, was selected for the prestigious ROSE program, and presented at the “Info-Practic” National Symposium on artificial intelligence. She participated in EU-supported initiatives like ERASMUS+ “Be a Buddy, Not a Bully” and contributed to major national projects, including the ongoing PNRR-funded research on personalized bone regeneration. Her work on cutting-edge nanostructures and her leadership in volunteer networks demonstrate her well-rounded excellence and dedication to scientific and societal progress.

Research Focus 

Teodora focuses on biomedical applications of nanotechnology, with a keen interest in targeted drug delivery, biopolymeric material synthesis, and regenerative medicine. Her Master’s research and publications revolve around understanding how nanostructures interact with cellular systems to improve treatment precision in diseases like multiple myeloma. She also explores the use of 3D printed biomaterials and advanced materials characterization techniques (SEM, DSC, DMA). Her interdisciplinary research combines materials science, molecular biology, and bioengineering to design patient-specific, low-toxicity solutions, positioning her at the frontier of precision and personalized medicine.

Publication Top Notes

Title: Nanostructures: An Efficient Drug Delivery Platform for Therapy of Multiple Myeloma
Year: 2025

Conclusion

Teodora Eliana Petcov is a highly promising emerging researcher whose interdisciplinary approach, early scientific contributions, and strong practical expertise align closely with the vision of the Best Researcher Award. Her dedication to innovation in biomaterials, nanotechnology, and regenerative medicine showcases both depth and futuristic relevance.